P&S Intelligence

The cardiac biomarkers market is set to reach $44.6B by 2030, driven by rising heart disease cases, AI-driven diagnostics, and growing demand for point-of-care testing.

The U.S. biologics CDMO market is set to grow at an 11.7% CAGR, reaching $9.08B by 2032, driven by rising biologics demand, aging population, and tech advancements.

According to the latest market research study published by P&S Intelligence , the global patient temperature monitoring market to reach USD 4.1 billion in 2024.

The orthopedic biomaterials market is set to grow at a 7.3% CAGR, reaching $38.8B by 2032, driven by 3D printing, personalized implants, and advanced surgeries.

The digital biomarkers market is set to grow at a 29% CAGR, reaching $23.5B by 2032, driven by AI, mHealth, and rising demand for remote patient monitoring.

The U.S. embolotherapy market is set to grow at a 7.9% CAGR, reaching $2.69B by 2032, driven by rising chronic diseases, tech advancements, and minimal invasiveness.

The global X-ray imaging market will reach $10.9 billion by 2032, driven by digital advancements, rising chronic diseases, and growing demand for early diagnosis.

Asia-Pacific is leading the routing market surge, driven by rapid digital transformation, rising internet penetration, and IT infrastructure growth.

The smart fleet management market is set to grow at an 8.2% CAGR, reaching $849.1B by 2030, driven by AI, telematics, and rising demand for cloud solutions.

The ESG reporting software market is set to grow at a 17.5% CAGR, reaching $2.1B by 2030, driven by regulations, sustainability trends, and tech advancements.